TLPPF
Price
$8.88
Change
-$0.16 (-1.77%)
Updated
Sep 8 closing price
Capitalization
2.98B
UCBJY
Price
$123.72
Change
+$2.43 (+2.00%)
Updated
Sep 8 closing price
Capitalization
46.05B
49 days until earnings call
Interact to see
Advertisement

TLPPF vs UCBJY

Header iconTLPPF vs UCBJY Comparison
Open Charts TLPPF vs UCBJYBanner chart's image
Telix Pharmaceutical
Price$8.88
Change-$0.16 (-1.77%)
Volume$180
Capitalization2.98B
UCB S.A
Price$123.72
Change+$2.43 (+2.00%)
Volume$30.92K
Capitalization46.05B
TLPPF vs UCBJY Comparison Chart in %
Loading...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLPPF vs. UCBJY commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLPPF is a Hold and UCBJY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (TLPPF: $8.88 vs. UCBJY: $123.72)
Brand notoriety: TLPPF and UCBJY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TLPPF: 2% vs. UCBJY: 79%
Market capitalization -- TLPPF: $2.98B vs. UCBJY: $46.05B
TLPPF [@Biotechnology] is valued at $2.98B. UCBJY’s [@Biotechnology] market capitalization is $46.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLPPF’s FA Score shows that 1 FA rating(s) are green whileUCBJY’s FA Score has 2 green FA rating(s).

  • TLPPF’s FA Score: 1 green, 4 red.
  • UCBJY’s FA Score: 2 green, 3 red.
According to our system of comparison, UCBJY is a better buy in the long-term than TLPPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLPPF’s TA Score shows that 4 TA indicator(s) are bullish while UCBJY’s TA Score has 3 bullish TA indicator(s).

  • TLPPF’s TA Score: 4 bullish, 4 bearish.
  • UCBJY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, UCBJY is a better buy in the short-term than TLPPF.

Price Growth

TLPPF (@Biotechnology) experienced а -9.85% price change this week, while UCBJY (@Biotechnology) price change was +5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.04%. For the same industry, the average monthly price growth was +10.49%, and the average quarterly price growth was +34.78%.

Reported Earning Dates

UCBJY is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Biotechnology (+1.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UCBJY($46.1B) has a higher market cap than TLPPF($2.98B). TLPPF has higher P/E ratio than UCBJY: TLPPF (380.85) vs UCBJY (30.79). UCBJY YTD gains are higher at: 26.319 vs. TLPPF (-40.701). UCBJY has higher annual earnings (EBITDA): 2.34B vs. TLPPF (41.7M). UCBJY has more cash in the bank: 2.01B vs. TLPPF (207M). TLPPF has less debt than UCBJY: TLPPF (418M) vs UCBJY (2.88B). UCBJY has higher revenues than TLPPF: UCBJY (6.85B) vs TLPPF (638M).
TLPPFUCBJYTLPPF / UCBJY
Capitalization2.98B46.1B6%
EBITDA41.7M2.34B2%
Gain YTD-40.70126.319-155%
P/E Ratio380.8530.791,237%
Revenue638M6.85B9%
Total Cash207M2.01B10%
Total Debt418M2.88B15%
FUNDAMENTALS RATINGS
TLPPF vs UCBJY: Fundamental Ratings
TLPPF
UCBJY
OUTLOOK RATING
1..100
6228
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
5718
SMR RATING
1..100
9292
PRICE GROWTH RATING
1..100
9341
P/E GROWTH RATING
1..100
599
SEASONALITY SCORE
1..100
1250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UCBJY's Valuation (3) in the null industry is significantly better than the same rating for TLPPF (93). This means that UCBJY’s stock grew significantly faster than TLPPF’s over the last 12 months.

UCBJY's Profit vs Risk Rating (18) in the null industry is somewhat better than the same rating for TLPPF (57). This means that UCBJY’s stock grew somewhat faster than TLPPF’s over the last 12 months.

UCBJY's SMR Rating (92) in the null industry is in the same range as TLPPF (92). This means that UCBJY’s stock grew similarly to TLPPF’s over the last 12 months.

UCBJY's Price Growth Rating (41) in the null industry is somewhat better than the same rating for TLPPF (93). This means that UCBJY’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's P/E Growth Rating (5) in the null industry is significantly better than the same rating for UCBJY (99). This means that TLPPF’s stock grew significantly faster than UCBJY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLPPFUCBJY
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
44%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 8 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
45%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICFX17.740.16
+0.91%
Lord Abbett International Equity F
CFNCX91.510.44
+0.48%
American Funds Fundamental Invs 529C
HEOYX18.400.08
+0.44%
Hartford Climate Opportunities Y
MFWIX17.850.06
+0.34%
MFS Global Total Return I
JFNIX70.64N/A
N/A
Janus Henderson Global Life Sciences I

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and BDTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-1.77%
BDTX - TLPPF
22%
Poorly correlated
+3.74%
ITOS - TLPPF
21%
Poorly correlated
N/A
RCUS - TLPPF
21%
Poorly correlated
-6.15%
ORMP - TLPPF
21%
Poorly correlated
+3.14%
ABOS - TLPPF
20%
Poorly correlated
-2.08%
More

UCBJY and

Correlation & Price change

A.I.dvisor tells us that UCBJY and SRPT have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and SRPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
+2.01%
SRPT - UCBJY
21%
Poorly correlated
-5.93%
DBVT - UCBJY
21%
Poorly correlated
-2.97%
NONOF - UCBJY
20%
Poorly correlated
-0.58%
ZLDPF - UCBJY
13%
Poorly correlated
N/A
TLPPF - UCBJY
13%
Poorly correlated
-1.77%
More